Related Experiment Video
Updated: Apr 7, 2026

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
Versatile myeloid cell subsets contribute to tuberculosis-associated inflammation.
Anca Dorhoi1, Stefan H E Kaufmann1
1Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.
Tuberculosis (TB) involves complex myeloid cell roles in lung inflammation. Understanding these cells, including dendritic cells (DCs), macrophages, neutrophils (PMNs), and myeloid-derived suppressor cells (MDSCs), is key for developing new TB treatments.
Area of Science:
- Immunology
- Cellular Biology
- Pathology
Background:
- Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a major global health concern.
- Myeloid cell subsets play critical, specialized roles in TB pathogenesis, influencing both protection and disease progression.
- Diverse phenotypes within myeloid populations differentially impact lung inflammation and granuloma formation.
Purpose of the Study:
- To review the multifaceted contributions of various myeloid cell subsets to inflammation in TB.
- To highlight the interactions between Mtb and myeloid cells within the lung.
- To elucidate the role of myeloid cells in TB-related lung pathology.
Main Methods:
- Review of current literature on cellular immunology and TB.
- Analysis of the roles of dendritic cells (DCs), macrophages, polymorphonuclear neutrophils (PMNs), and myeloid-derived suppressor cells (MDSCs) in TB.
- Examination of myeloid cell interactions with Mtb and their impact on lung inflammation.
Main Results:
- Dendritic cells (DCs) are crucial for adaptive immunity induction.
- Macrophages are primary sites of Mtb infection within granulomas.
- Polymorphonuclear neutrophils (PMNs) and myeloid-derived suppressor cells (MDSCs) contribute to lung damage and excessive inflammation.
Conclusions:
- Understanding the diverse functions of myeloid cell subsets in TB is essential for host-directed therapies.
- Targeting myeloid cell-driven inflammation could lead to novel therapeutic strategies for TB.
- Further research into myeloid cell heterogeneity will inform the development of effective immune interventions for TB.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Differentiation of Common Myeloid Progenitor Cells
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

